Merck Shares Rated ‘Overweight’ by JPMorgan In Advance Of Earnings
Investment banking giant JPMorgan has maintained its ‘Overweight’ rating for Merck (ETR: MRK), signalling confidence in the company’s performance ahead of its second-quarter earnings report on 30th July.…


















